Market Watch: Mind Medicine Inc (MNMD)’s Noteworthy Gain, Closing at 6.06

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Mind Medicine Inc’s stock clocked out at $6.06, up 0.83% from its previous closing price of $6.01. In other words, the price has increased by $0.83 from its previous closing price. On the day, 0.76 million shares were traded. MNMD stock price reached its highest trading level at $6.107 during the session, while it also had its lowest trading level at $5.92.

Ratios:

To gain a deeper understanding of MNMD’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.92 and its Current Ratio is at 5.92. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.12.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on July 24, 2024, initiated with a Buy rating and assigned the stock a target price of $36.

On May 29, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $27.

On April 15, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $20.Leerink Partners initiated its Outperform rating on April 15, 2024, with a $20 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 23 ’24 when GRYSKA DAVID W bought 3,500 shares for $5.98 per share. The transaction valued at 20,930 led to the insider holds 17,351 shares of the business.

Barrow Robert bought 500 shares of MNMD for $3,155 on Aug 19 ’24. The Chief Executive Officer now owns 565,043 shares after completing the transaction at $6.31 per share. On Aug 20 ’24, another insider, Barrow Robert, who serves as the Chief Executive Officer of the company, bought 500 shares for $6.12 each. As a result, the insider paid 3,060 and bolstered with 565,543 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 493468800 and an Enterprise Value of 218317520.

Stock Price History:

Over the past 52 weeks, MNMD has reached a high of $12.22, while it has fallen to a 52-week low of $2.41. The 50-Day Moving Average of the stock is -17.94%, while the 200-Day Moving Average is calculated to be -8.43%.

Shares Statistics:

It appears that MNMD traded 1.33M shares on average per day over the past three months and 981970 shares per day over the past ten days. A total of 41.10M shares are outstanding, with a floating share count of 27.15M. Insiders hold about 3.60% of the company’s shares, while institutions hold 144.17% stake in the company. Shares short for MNMD as of 1723680000 were 9781465 with a Short Ratio of 7.34, compared to 1721001600 on 9244756. Therefore, it implies a Short% of Shares Outstanding of 9781465 and a Short% of Float of 12.020000999999999.

Most Popular